Bambusa Therapeutics
As of the edition of 20 October 2026, Bambusa Therapeutics runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Total | 2 |
Where its trials are
- Immune system: 2 trials led
- Inherited and neonatal: 2 trials led
- Lungs and airways: 2 trials led